| 1. Domain | 1.1 Scope of the Domain | Boundaries | The range of phenomena the science includes and excludes. | Focuses on how changes in developmental processes drive evolutionary variation in form, body plans, morphology, and life cycles. Includes regulatory-network evolution, heterochrony, heterotopy, modularity, constraint, developmental plasticity, deep homology, and comparative embryology. Excludes purely ecological or genetic-population dynamics unless linked to developmental mechanisms, and excludes functional physiology not tied to developmental patterning. |
| | Scale | The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic). | Operates from gene-regulatory elements (bp-scale) to whole embryos and body plans (mm–cm scale); temporal scales spanning embryonic development, evolutionary timescales (thousands to millions of years), and species divergence across clades. |
| 1.2 Ontological Commitments | Entities | The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.). | Gene regulatory networks (GRNs), developmental modules, enhancers and cis-regulatory elements, transcription factors, signaling pathways (Wnt, Hedgehog, BMP), conserved patterning genes (Hox, Pax, Sox), morphological traits, embryonic domains, ancestral developmental programs. |
| | Properties | The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.). | Developmental modularity, pleiotropy, constraint, evolvability, heterochronic timing, spatial deployment of developmental programs, regulatory sensitivity, morphological plasticity, conservation of regulatory motifs. |
| | Categories | The basic ontological types used to classify domain elements (substances, processes, relations, structures). | Types of developmental change (heterochrony, heterotopy, heterometry, heterotypy), homology categories (serial, deep, molecular), modular units (segments, appendage modules), evolutionary trajectories (co-option, innovation, loss), patterning mechanisms (axis, segmentation, organ-specific GRNs). |
| 1.3 State-Variables | Variables | The measurable or definable properties that describe system conditions. | Gene-expression levels, enhancer activity, spatial transcription-factor domains, timing of developmental events, GRN connectivity, module boundary positions, morphological trait metrics, evolutionary divergence in developmental sequences. |
| | Parameterization | How variables encode and represent the system’s state. | System encoded via gene-expression matrices, cis-regulatory sequence maps, GRN wiring diagrams, developmental-timing curves, morphometric trait datasets, comparative embryonic staging, and phylogenetically aligned developmental timelines. |
| 1.4 Admissible Idealizations | Simplifications | Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases). | Treating developmental modules as independent; ignoring pleiotropic trade-offs; assuming linear developmental changes; reducing GRN evolution to single enhancer gains/losses; modeling species differences as simple parameter shifts; treating homology as binary. |
| | Validity Conditions | The limits and contexts in which idealizations hold or break down. | Fail with strongly interconnected GRNs, complex epistatic regulatory evolution, species with extreme plasticity, developmental systems with non-modular organization, or traits influenced by nonlinear feedback processes. |
| 1.5 Domain Assumptions | Structural Assumptions | Background ontological stances such as determinism, continuity, randomness, discreteness. | Development shapes evolutionary potential; regulatory-network changes drive morphological diversification; conserved GRN cores constrain form; modularity enables innovation; developmental timing and spatial pattern shifts produce major morphological differences; homology reflects shared developmental underpinnings. |
| | Implicit Commitments | Unstated but necessary assumptions that shape the field’s conceptual structure. | Assumes developmental programs remain stable enough for comparison, GRN architecture is inferable, morphological traits have developmental bases, and evolutionary differences arise from modifiable regulatory inputs rather than random morphological drift. |
| 1.6 Internal Coherence Requirements | Consistency | The demand that domain concepts do not contradict one another. | GRN evolution, developmental timing changes, morphological shifts, and homology assignments must align; inferred evolutionary transitions must remain coherent across molecular, anatomical, and developmental data. |
| | Compatibility | The requirement that entities, variables, and assumptions fit together into a unified descriptive framework. | Gene regulation, GRN topology, developmental timing, spatial patterning, morphological trait evolution, and phylogenetic relationships must integrate into a unified developmental–evolutionary framework. |
| 2. Evidence Layer | 2.1 Observable Phenomena | Observables | The aspects of the domain that can produce detectable signals accessible to measurement. | Changes in gene-expression patterns across species; shifts in enhancer activity; alterations in developmental timing (heterochrony); spatial redeployment of regulatory programs (heterotopy); morphological variants in embryos and adults; conserved and divergent GRN modules; embryonic-pattern differences aligned to phylogeny. |
| | Detection Limits | The boundaries of what can be resolved or sensed by current instruments or methods. | Limited by spatial resolution of early embryos, difficulty reconstructing ancestral states, low expression of key regulators, poor fossil preservation of soft tissues, incomplete genomes for many species, and weak phylogenetic signal in rapidly evolving regulatory elements. |
| 2.2 Measurement Systems | Units | Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison. | Expression levels (counts/FPKM/TPM), enhancer activity intensity, spatial coordinates (µm) for expression domains, embryonic-stage timing (hours/days), morphometric distances, phylogenetic branch lengths, regulatory motif scores. |
| | Instruments | Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements. | RNA-seq, ATAC-seq, ChIP-seq, Hi-C, in situ hybridization, single-cell sequencing, light-sheet microscopy, comparative embryonic imaging systems, reporter constructs, CRISPR-based enhancer assays, phylogenomic pipelines. |
| 2.3 Operational Definitions | Definitions | Terms defined by specific measurement procedures, ensuring empirical clarity. | Heterochrony defined as a shift in timing of developmental events; heterotopy as a spatial shift in gene or tissue deployment; homology defined by shared developmental origin; modularity defined by semi-independent GRN units; deep homology defined by conserved regulatory architecture underlying disparate traits. |
| | Procedures | The explicit steps required to perform a measurement in a reproducible way. | Comparative gene-expression profiling, enhancer-reporter assays, cross-species alignment of developmental stages, mapping GRN changes, perturbing regulatory sequences, quantifying trait morphology, performing ancestral-state reconstructions. |
| 2.4 Data Acquisition | Protocols | Formal processes for gathering data under controlled or standardized conditions. | Standardized staging across species, consistent imaging parameters, controlled cross-species sampling windows, replicated developmental transcriptomes, validated enhancer assays, uniform morphometric procedures, and phylogenetically balanced sampling. |
| | Sampling | Rules determining which subset of the domain is measured and how representative it is. | Sampling across species spanning key phylogenetic divergences, across developmental timecourses, across tissue domains, including both ancestral and derived lineages, and ensuring representation of convergent and divergent morphologies. |
| 2.5 Data Character & Format | Data Types | The form raw evidence takes (time series, spectra, images, counts, qualitative records). | Expression matrices, enhancer-activity maps, sequence alignments, GRN wiring diagrams, morphometric trait datasets, phylogenetic reconstructions, ancestral-state predictions, comparative embryo images. |
| | Resolution | The granularity or precision with which data is captured. | Determined by sequencing depth, spatial imaging resolution, accuracy of stage alignment across species, motif-detection sensitivity, and granularity of morphometric measurements. |
| 2.6 Reliability & Calibration | Calibration | Adjustment procedures ensuring instruments produce accurate results. | Cross-species normalization of expression datasets, calibration of reporter-signal intensity, orthology verification, embryo-staging calibration, motif-scoring thresholds, and validation of regulatory-element alignment. |
| | Error Characterization | Identification and quantification of noise, uncertainty, bias, and measurement error. | Identifying errors in gene-expression normalization, misalignment of developmental stages, incorrect homology assignments, incomplete regulatory annotations, phylogenetic reconstruction uncertainty, and distinguishing biological divergence from technical noise. |
| 3. Structural Layer | 3.1 Patterns & Regularities | Laws / Relations | Stable, repeatable patterns governing how observables behave across conditions. | Changes in development predictably alter morphology; conserved GRN cores underlie homologous structures; small regulatory changes often produce large morphological effects; heterochrony and heterotopy produce repeatable morphological outcomes across lineages; evolutionary innovations frequently arise via co-option of ancestral developmental modules. |
| | Invariants | Quantities or properties that remain constant under transformations (symmetries, conservation laws). | Deep homology of GRN architecture; conservation of body-axis patterning systems; stability of Hox colinearity; persistent modular organization of developmental processes; invariant relationships between regulatory-gene expression domains and morphological outcomes across species. |
| 3.2 Causal Architecture | Mechanisms | Underlying processes or structures that produce the observed regularities. | Regulatory mutations alter gene-expression domains; enhancer gain/loss shifts developmental timing or spatial patterning; changes in GRN connectivity reshape morphogenesis; feedback loops stabilize developmental modules; co-option repurposes existing GRNs for new traits; developmental constraints canalize viable evolutionary trajectories. |
| | Pathways | Organized sequences of interactions forming a causal chain or network. | Regulatory change → altered gene expression → modified developmental process → morphological change; enhancer mutation → spatial redeployment → trait novelty; heterochrony → timing shift → altered size/shape; GRN perturbation → new module interactions → evolutionary innovation. |
| 3.3 Theoretical Vocabulary | Concepts | Core terms that encode the domain’s structure (force, gene, equilibrium, field). | Deep homology, heterochrony, heterotopy, modularity, co-option, constraint, evolvability, GRN architecture, enhancer evolution, morphospace, developmental plasticity, canalization, innovation, divergence. |
| | Classifications | Taxonomies, categories, or typologies that organize entities and relations. | Developmental-change types (heterochrony, heterotopy, heterometry, heterotypy), homology classes (serial, molecular, deep), developmental modules (segmental, appendage, organ-specific), evolutionary GRN alterations (gain, loss, rewiring). |
| 3.4 Formal Representations | Equations | Mathematical constructs expressing laws, relations, or mechanisms. | GRN dynamical equations, regulatory-threshold models, reaction–diffusion patterning equations adapted to evolutionary simulations, heterochronic timing functions, morphometric divergence equations, fitness landscapes constrained by developmental pathways. |
| | Models | Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena. | GRN-evolution models, enhancer-evolution simulations, heterochrony models, modularity and co-option models, comparative-embryology alignment models, trait-evolution models incorporating developmental constraints, lineage-specific developmental trajectory reconstructions. |
| 3.5 Idealized Structures | Simplified Models | Purposeful abstractions that capture essential dynamics while omitting irrelevant detail. | Treating modules as fully independent; assuming single-gene regulatory changes; ignoring pleiotropy; simplifying GRNs to binary ON/OFF states; approximating developmental timing shifts as linear; ignoring mechanical influences on development. |
| | Limit Conditions | Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear). | Fail with high GRN complexity, nonlinear regulatory interactions, strong pleiotropy, species with extreme plasticity, convergent evolution producing misleading similarities, or traits dependent on multi-layered gene–mechanical feedback. |
| 3.6 Integrative Frameworks | Unifying Theories | Higher-order structures that connect disparate laws or mechanisms under a coherent whole. | Evo–Devo unifies development and evolution through GRN architecture, modularity, and regulatory change; morphological evolution emerges from alterations in developmental programs; deep homology shows conserved architecture behind diverse forms; developmental constraints shape evolutionary pathways. |
| | Interdisciplinary Links | Points where the theory connects to adjacent sciences or larger explanatory systems. | Connects to molecular evolution (regulatory sequence change), paleontology (fossil trait reconstruction), developmental biology (GRN function), genetics (mutational landscapes), systems biology (network dynamics), and comparative morphology (trait homology). |
| 4. Method Layer | 4.1 Inquiry Design | Experimental Design | Structured plans for manipulating variables to test causal claims. | Manipulating enhancers or regulatory genes across species; CRISPR-editing developmental genes to test causality; transplanting tissues or organizers; altering timing of gene expression; perturbing signaling pathways to assess evolutionary shifts in developmental processes; engineering ancestral-state enhancers to test functional divergence. |
| | Observational Design | Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments). | Comparative embryonic imaging; mapping natural variation in gene-expression domains; observing heterochrony across closely related species; documenting morphological divergence; profiling GRN changes without perturbation; tracking conserved vs divergent embryonic stages. |
| 4.2 Testing & Validation | Hypothesis Testing | Procedures for evaluating whether evidence supports or contradicts specific claims. | Testing whether specific regulatory changes drive morphological differences; evaluating enhancer necessity/sufficiency; comparing predicted vs observed spatial–temporal expression changes; testing homology predictions with GRN architecture; validating evolutionary timing shifts using controlled expression systems. |
| | Replication | The requirement that results be independently reproducible under similar conditions. | Repeating cross-species enhancer assays, re-running expression analyses, confirming morphological measurements, validating GRN perturbation results, replicating staging alignments, and re-sequencing regulatory regions for accuracy. |
| 4.3 Inference & Evaluation | Statistical Inference | Rules for drawing conclusions from noisy or incomplete data. | Estimating divergence in gene-expression patterns, inferring regulatory-caused morphological changes, performing ancestral-state reconstructions, modeling GRN evolution, quantifying variance in timing/plasticity, and assessing uncertainty in homology and evolutionary trajectories. |
| | Model Comparison | Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models. | Comparing alternative GRN-evolution models, testing different enhancer-evolution scenarios, comparing heterochrony vs heterotopy explanations, evaluating trait-evolution models with developmental constraints, and contrasting phylogenetic reconstructions that incorporate vs ignore developmental data. |
| 4.4 Error Management | Error Analysis | Identification and quantification of random and systematic errors. | Identifying mis-staged embryos, alignment errors across species, sequencing noise, incorrect homology assignments, false-positive enhancer activity, expression-quantification errors, batch effects across comparative datasets, and phylogenetic uncertainty. |
| | Bias Control | Methods for minimizing subjective, instrumental, or procedural biases. | Standardizing staging and imaging conditions, using orthology-verified genes, balancing species sampling, controlling for environmental variation, blinding morphological scoring, normalizing cross-species expression datasets, and validating enhancer activity with multiple assays. |
| 4.5 Adjudication & Revision | Peer Scrutiny | Collective evaluation of claims through critique, review, and debate. | Reanalyzing regulatory evolution with independent pipelines, revisiting homology assignments, comparing GRN architectures across multiple datasets, reconciling morphological and molecular evidence, and updating hypotheses when contradictions arise. |
| | Theory Revision | Procedures for modifying, replacing, or discarding models based on new evidence. | Revising developmental-evolution frameworks when new GRN motifs are discovered, adjusting models of trait innovation based on new enhancer functions, integrating evidence of convergent evolution, or rewriting lineage histories when deeper homology or new regulatory modules are identified. |
| 4.6 Integrity Conditions | Transparency | Requirements to disclose methods, data, assumptions, and limitations. | Full disclosure of cross-species sampling, enhancer constructs, CRISPR protocols, staging criteria, GRN modeling assumptions, phylogenetic parameters, and limitations; open release of raw expression and regulatory datasets where feasible. |
| | Ethical Standards | Norms ensuring responsible conduct in experimentation, data handling, and publication. | Ethical handling of embryos and comparative-species material, respect for biodiversity constraints, responsible genomic editing, accurate reporting of evolutionary interpretations, and adherence to ethical principles in cross-species developmental research. |